Suppr超能文献

视网膜中央静脉阻塞后的新生血管并发症。

Neovascular complications after central retinal vein occlusion.

作者信息

Evans K, Wishart P K, McGalliard J N

机构信息

St Paul's Eye (Glaucoma) Unit, Royal Liverpool University Hospital, UK.

出版信息

Eye (Lond). 1993;7 ( Pt 4):520-4. doi: 10.1038/eye.1993.113.

Abstract

An 8-year retrospective study of patients suffering a central retinal vein occlusion (CRVO) was undertaken to study secondary new vessel formation and whether pathologies known to predispose to CRVO influenced the occurrence of these neovascular complications and their responsiveness to treatment. Seventy-three patients were studied. Ocular neovascularisation had occurred in 60%. More specifically 39% developed neovascular glaucoma. Panretinal photocoagulation produced regression in only 37% of those with established neovascularisation and was unsuccessful in preventing neovascularisation in five patients treated prophylactically. Patients with pre-existing primary open angle glaucoma (POAG) were statistically more likely to develop ocular neovascularisation (p = 0.02), which was also less responsive to laser therapy (p = 0.02). Adequate prior glaucoma therapy did not protect against this enhanced complication rate. It was concluded that POAG is a significant risk factor for developing ocular neovascularisation after CRVO which will be refractory to laser therapy.

摘要

开展了一项针对视网膜中央静脉阻塞(CRVO)患者的8年回顾性研究,以研究继发性新生血管形成,以及已知易患CRVO的病理状况是否会影响这些新生血管并发症的发生及其对治疗的反应。共研究了73例患者。60%的患者发生了眼部新生血管形成。更具体地说,39%的患者发展为新生血管性青光眼。全视网膜光凝仅使37%已形成新生血管的患者病情消退,并且在5例预防性治疗的患者中未能成功预防新生血管形成。既往患有原发性开角型青光眼(POAG)的患者在统计学上更易发生眼部新生血管形成(p = 0.02),对激光治疗的反应也较差(p = 0.02)。充分的既往青光眼治疗并不能预防这种并发症发生率的增加。得出的结论是,POAG是CRVO后发生眼部新生血管形成的一个重要危险因素,且对激光治疗难治。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验